HIGHLIGHTS
- who: Rajiv Shah and colleagues from the College of Medical, Veterinary and Life Sciences, MRC-University of Glasgow Centre for have published the research: Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment, in the Journal: Viruses 2022, 1678 of 24/06/2022
- what: The authors aimed to investigate glecaprevir and pibrentasvir (GP) treatment outcomes in cohort of patients with genotype 2a infection. Whole genomes generated as part of this study have been submitted to GenBank (www.ncbi.nlm.nih.gov/genbank/, accessed on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.